Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-16

Clinical Trial Update: Safety and Efficacy of I 0401 in the Treatment of Tibial Plateau Fractures Requiring Grafting [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety and efficacy of I 0401 for tibial plateau fractures requiring grafting has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • I 0401

Snippet

Sponsor: Kuros Biosurgery AG | Conditions: Tibia Plateau Fractures | Phase 2 | Status: COMPLETED